Renalase (RNLS) is a protein exhibiting various functions inside and outside cells. A series of synthetic peptides, corresponding to the fragments of the RNLS amino acid sequence, may reproduce the effects of the full-length RNLS. In this study we have investigated the interaction of proteins in the mitochondrial brain fraction of rats with the full-length RNLS and its peptides RP211-223 (peptide 1) and RP224-232 (peptide 2) immobilized on CNBr-activated Sepharose. Proteomic profiles of proteins bound to the full-length RNLS and its peptide RP211-223 were significantly different, whereas RP224-232 bound a small number of proteins (6), similar to those bound to the full-length RNLS. However, most proteins bound to RNLS and its peptides were multifunctional and associated with neurodegenerative pathology (Alzheimer’s and Parkinson’s diseases, etc.).
Download PDF:
Keywords: renalase, renalase peptides RP211-223 and RP224-232, proteomic profiling, rat brain mitochondria, neurodegeneration
Citation:
Buneeva O.A., Fedchenko V.I., Kaloshina S.A., Kaloshin A.A., Zgoda V.G., Medvedev A.E. (2026) Interaction of renalase and its peptides RP211-223 and RP224-232 with the mitochondrial fraction of rat brain: a link to neurodegeneration?. Biomeditsinskaya Khimiya, 72(3), 220-229.
Buneeva O.A. et al. Interaction of renalase and its peptides RP211-223 and RP224-232 with the mitochondrial fraction of rat brain: a link to neurodegeneration? // Biomeditsinskaya Khimiya. - 2026. - V. 72. -N 3. - P. 220-229.
Buneeva O.A. et al., "Interaction of renalase and its peptides RP211-223 and RP224-232 with the mitochondrial fraction of rat brain: a link to neurodegeneration?." Biomeditsinskaya Khimiya 72.3 (2026): 220-229.
Buneeva, O. A., Fedchenko, V. I., Kaloshina, S. A., Kaloshin, A. A., Zgoda, V. G., Medvedev, A. E. (2026). Interaction of renalase and its peptides RP211-223 and RP224-232 with the mitochondrial fraction of rat brain: a link to neurodegeneration?. Biomeditsinskaya Khimiya, 72(3), 220-229.
References
Xu J., Li G., Wang P., Velazquez H., Yao X., Li Y., Wu Y., Peixoto A., Crowley S., Desir G.V. (2005) Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J. Clin. Invest., 115(5), 1275–1280. CrossRef Scholar google search
Medvedev A.E., Veselovsky A.V., Fedchenko V.I. (2010) Renalase, a new secretory enzyme responsible for selective degradation of catecholamines: achievements and unsolved problems. Biochemistry (Moscow), 75(8), 951–958. CrossRef Scholar google search
Baroni S., Milani M., Pandini V., Pavesi G., Horner D., Aliverti A. (2013) Is renalase a novel player in catecholaminergic signaling? The mystery of the catalytic activity of an intriguing new flavoenzyme. Curr. Pharm. Des., 19(14), 2540–2551. CrossRef Scholar google search
Desir G.V., Peixoto A.J. (2014) Renalase in hypertension and kidney disease. Nephrol. Dial. Transplant., 29(1), 22–28. CrossRef Scholar google search
Beaupre B.A., Hoag M.R., Roman J., Försterling F.H., Moran G.R. (2015) Metabolic function for human renalase: oxidation of isomeric forms of β-NAD(P)H that are inhibitory to primary metabolism. Biochemistry, 54(3), 795–806. CrossRef Scholar google search
Wang Y., Safirstein R., Velazquez H., Guo X.-J., Hollander L., Chang J., Chen T.-M., Mu J.-J., Desir G.V. (2017) Extracellular renalase protects cells and organs by outside-in signalling. J. Cell. Mol. Med., 21(7), 1260–1265. CrossRef Scholar google search
Kolodecik T.R., Guo X., Shugrue C.A., Guo X., Desir G.V., Wen L., Gorelick F. (2024) Renalase peptides reduce pancreatitis severity in mice. Am. J. Physiol. Gastrointest. Liver Physiol., 327(3), G466–G480. CrossRef Scholar google search
Medvedev A., Kopylov A., Fedchenko V., Buneeva O. (2020) Is renalase ready to become a biomarker of ischemia? Int. J. Cardiol., 307, 179. CrossRef Scholar google search
Fedchenko V.I., Veselovsky A.V., Kopylov A.T., Kaloshina S.A., Medvedev A.E. (2022) Renalase may be cleaved in blood. Are blood chymotrypsin-like enzymes involved? Med. Hypotheses, 165, 110895. CrossRef Scholar google search
Buneeva O.A., Fedchenko V.I., Kaloshina S.A., Zavyalova M.G., Zgoda V.G., Medvedev A.E. (2024) Proteomic profiling of renal tissue of normo- and hypertensive rats with the renalase peptide RP220 as an affinity ligand. Biomeditsinskaya Khimiya, 70(3), 145–155. CrossRef Scholar google search
Xiong X., Xu Y.-Z., Zhang Y., Zhang H.-F., Dou T.-M., Li X.-Y., Xu Z.-Y., Cui C.-P., Li X.-L., Li B.-Y. (2025) Renalase overexpression-mediated excessive metabolism of peripheral dopamine, DOPAL accumulation, α-synuclein aggregation in baroreflex afferents contribute to neuronal degeneration and autonomic dysfunction. Biomedicines, 13(5), 1243. CrossRef Scholar google search
Alfaidi M.S., Wenger L.M.D., Szebényi K., Stoker T.B., He X., Fazal S.V., Sebestikova J., Jassim A., Gilbertson R.J., Garza R., Jakobsson J., Spillantini M.G., Barker R.A., Kuan W.-L. (2026) Early α-synucleinmediated mitochondrial dysfunction in a human cell model of Parkinson’s disease dementia. Commun. Biol., DOI: 10.1038/s42003-026-10134-x. CrossRef Scholar google search
Burbulla L.F., Song P., Mazzulli J.R., Zampese E., Wong Y.C., Jeon S., Santos D.P., Blanz J., Obermaier C.D., Strojny C., Savas J.N., Kiskinis E., Zhuang X., Krüger R., Surmeier D.J., Krainc D. (2017) Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease. Science, 357(6357), 1255–1261. CrossRef Scholar google search
Guo X., Chen R., Shugrue C., Shang F.-F., Milian R.G., Moller H., Licznerski P., Chen T., Kibbey R., M’Saad O., Tian Y., Bewersdorf J., Giordano F., Gorelick F.S., Safirstein R., Jonas E.A., Desir G.V. (2025) Renalase activates mitochondrial leak metabolism in response to cellular stress and to repair damage after injury. bioRxiv [Preprint], 2025.08.19.671117. CrossRef Scholar google search
Fedchenko V.I., Kaloshin A.A. (2019) A simplified method for obtaining cDNA of low-copy and silent eukaryotic genes using human renalase as an example. Biomedical Chemistry: Research and Methods, 2(2), e00101. CrossRef Scholar google search
Fedchenko V., Kaloshin A., Mezhevikina L., Buneeva O., Medvedev A. (2013) Construction of the coding sequence of the transcription variant 2 of the human renalase gene and its expression in the prokaryotic system. Int. J. Mol. Sci., 14(6), 12764–12779. CrossRef Scholar google search
Buneeva O.A., Kopylov A.T., Gnedenko O.V., Medvedeva M.V., Kapitsa I.G., Ivanova E.A., Ivanov A.S., Medvedev A.E. (2021) Changes in the mitochondrial subproteome of mouse brain Rpn13-binding proteins induced by the neurotoxin MPTP and the neuroprotector isatin. Biomeditsinskaya Khimiya, 67(1), 51–65. CrossRef Scholar google search
Pointer T.C., Gorelick F.S., Desir G.V. (2021) Renalase: a multi-functional signaling molecule with roles in gastrointestinal disease. Cells, 10(8), 2006. CrossRef Scholar google search
Buneeva O.A., Fedchenko V.I., Gnedenko O.V., Kaloshina S.A., Medvedeva M.V., Zavyalova M.G., Ivanov A.S., Zgoda V.G., Medvedev A.E. (2025) Interaction of rat kidney proteins with the renalase peptide RP220 and its potential proteolytic fragment RP224-232: a comparative proteomic analysis. Biomeditsinskaya Khimiya, 71(1), 65–70. CrossRef Scholar google search
Al-Jassar C., Bikker H., Overduin M., Chidgey M. (2013) Mechanistic basis of desmosome-targeted diseases. J. Mol. Biol., 425(21), 4006–4022. CrossRef Scholar google search
Yuan Z.-Y., Cheng L.-T., Wang Z.-F., Wu Y.-Q. (2021) Desmoplakin and clinical manifestation of desmoplakin cardiomyopathy. Chin. Med. J. (Engl.), 134(15), 1771–1779. CrossRef Scholar google search
Gawinecka J., Ciesielczyk B., Sanchez-Juan P., Schmitz M., Heinemann U., Zerr I. (2012) Desmoplakin as a potential candidate for cerebrospinal fluid marker to rule out 14-3-3 false positive rates in sporadic Creutzfeldt-Jakob disease differential diagnosis. Neurodegener. Dis., 9(3), 139–144. CrossRef Scholar google search
Bass-Zubek A.E., Godsel L.M., Delmar M., Green K.J. (2009) Plakophilins: multifunctional scaffolds for adhesion and signaling. Curr. Opin. Cell Biol., 21(5), 708–716. CrossRef Scholar google search
Wang H., Sun C., Liang Y., Zhang H., Tan Y. (2013) Identification of regulatory relationships in Parkinson’s disease. J. Mol. Neurosci., 51(1), 9–12. CrossRef Scholar google search
Didonna A., Opal P. (2019) The role of neurofilament aggregation in neurodegeneration: lessons from rare inherited neurological disorders. Mol. Neurodegener., 14, 19. CrossRef Scholar google search
Leite A.C., Martins T.S., Campos A., Costa V., Pereira C. (2022) Phosphoregulation of the ATP synthase beta subunit stimulates mitochondrial activity for G2/M progression. Adv. Biol. Regul., 85, 100905. CrossRef Scholar google search
Li J.-L., Lin T.-Y., Chen P.-L., Guo T.-N., Huang S.-Y., Chen C.-H., Lin C.-H., Chan C.-C. (2021) Mitochondrial function and Parkinson’s disease: from the perspective of the electron transport chain. Front. Mol. Neurosci., 14, 797833. CrossRef Scholar google search
Wang T., Zhao D., Zhang Y., Yu D., Liu G., Zhang K. (2024) Annexin A2: a double-edged sword in pathogen infection. Pathogens, 13(7), 564. CrossRef Scholar google search
Astillero-Lopez V., Villar-Conde S., Gonzalez-Rodriguez M., Flores-Cuadrado A., Ubeda-Banon I., Saiz-Sanchez D., Martinez-Marcos A. (2024) Proteomic analysis identifies HSP90AA1, PTK2B, ANXA2 in the human entorhinal cortex in Alzheimer’s disease: potential role in synaptic homeostasis and Aβ pathology through microglial and astroglial cells. Brain Pathol., 34(4), e13235. CrossRef Scholar google search
Young S.M. Jr., Neher E. (2009) Synaptotagmin has an essential function in synaptic vesicle positioning for synchronous release in addition to its role as a calcium sensor. Neuron, 63(4), 482–496. CrossRef Scholar google search
Glavan G., Schliebs R., Zivin M. (2009) Synaptotagmins in neurodegeneration. Anat. Rec., 292(12), 1849–1862. CrossRef Scholar google search
Herrmann D.N., Horvath R., Sowden J.E., Gonzalez M., Sanchez-Mejias A., Guan Z., Whittaker R.G., Almodovar J.L., Lane M., Bansagi B., Pyle A., Boczonadi V., Lochmüller H., Griffin H., Chinnery P.F., Lloyd T.E., Littleton J.T., Zuchner S. (2014) Synaptotagmin 2 mutations cause an autosomal-dominant form of Lambert-Eaton myasthenic syndrome and nonprogressive motor neuropathy. Am. J. Hum. Genet., 95(3), 332–339. CrossRef Scholar google search
Sandiford S.L., Dong Y., Pike A., Blumberg B.J., Bahia A.C., Dimopoulos G. (2015) Cytoplasmic actin is an extracellular insect immune factor which is secreted upon immune challenge and mediates phagocytosis and direct killing of bacteria, is a Plasmodium antagonist. PLOS Pathog., 11(2), e1004631. CrossRef Scholar google search
Sarkar S., Olsen A.L., Sygnecka K., Lohr K.M., Feany M.B. (2021) α-Synuclein impairs autophagosome maturation through abnormal actin stabilization. PLOS Genet., 17(2), e1009359. CrossRef Scholar google search
Cartelli D., Goldwurm S., Casagrande F., Pezzoli G., Cappelletti G. (2012) Microtubule destabilization is shared by genetic and idiopathic Parkinson’s disease patient fibroblasts. PLOS One, 7(5), e37467. CrossRef Scholar google search
Islam S.,Watanabe H. (2020) Versican: a dynamic regulator of the extracellular matrix. J. Histochem. Cytochem., 68(11), 763–775. CrossRef Scholar google search
Zhang Z.-W., Zhang J.-P., Zhou T.-T., Feng W.-H., Jiao B.-H. (2011) Does the expression of versican isoforms contribute to the pathogenesis of neurodegenerative diseases? Arch. Med. Res., 42(3), 258–260. CrossRef Scholar google search
Kumar A., Ganini D., Mason R.P. (2016) Role of cytochrome c in α-synuclein radical formation: implications of α-synuclein in neuronal death in Maneb- and paraquat-induced model of Parkinson’s disease. Mol. Neurodegener., 11, 70. CrossRef Scholar google search
Pauly B.S., Drubin D.G. (2007) Clathrin: an amazing multifunctional dreamcoat? Cell Host Microbe, 2(5), 288–290. CrossRef Scholar google search
Schreij A.M.A., Chaineau M., Ruan W., Lin S., Barker P.A., Fon E.A., McPherson P.S. (2015) LRRK2 localizes to endosomes and interacts with clathrin-light chains to limit Rac1 activation. EMBO Rep., 16(1), 79–86. CrossRef Scholar google search
Díaz-Ramos A., Roig-Borrellas A., García-Melero A., López-Alemany R. (2012) α-Enolase, a multifunctional protein: its role on pathophysiological situations. J. Biomed. Biotechnol., 2012, 156795. CrossRef Scholar google search
Pancholi V. (2001) Multifunctional alpha-enolase: its role in diseases. Cell. Mol. Life Sci., 58(7), 902–920. CrossRef Scholar google search
Patel S., Sinha A., Singh M.P. (2007) Identification of differentially expressed proteins in striatum of maneb- and paraquat-induced Parkinson’s disease phenotype in mouse. Neurotoxicol.Teratol., 29(5), 578–585. CrossRef Scholar google search
Poon H.F., Frasier M., Shreve N., Calabrese V., Wolozin B., Butterfield D.A. (2005) Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice — a model of familial Parkinson’s disease. Neurobiol. Dis., 18(3), 492–498. CrossRef Scholar google search
Blosa M., Sonntag M., Jäger C., Weigel S., Seeger J., Frischknecht R., Seidenbecher C.I., Matthews R.T., Arendt T., Rübsamen R., Morawski M. (2015) The extracellular matrix molecule brevican is an integral component of the machinery mediating fast synaptic transmission at the calyx of Held. J. Physiol., 593(19), 4341–4360. CrossRef Scholar google search
Lin X., Shi M., Masilamoni J.G., Dator R., Movius J., Aro P., Smith Y., Zhang J. (2015) Proteomic profiling in MPTP monkey model for early Parkinson disease biomarker discovery. Biochim. Biophys. Acta, 1854(7), 779–787. CrossRef Scholar google search
Jonesco D.S., Karsdal M.A., Henriksen K. (2020) The CNS-specific proteoglycan, brevican, its ADAMTS4- cleaved fragment show differential serological levels in Alzheimer’s disease, other types of dementia and non-demented controls: a cross-sectional study. PLOS One, 15(6), e0234632. CrossRef Scholar google search
Rodríguez-Bolaños M., Perez-Montfort R. (2019) Medical and veterinary importance of the moonlighting functions of triosephosphate isomerase. Curr. Protein Pept. Sci., 20(4), 304–315. CrossRef Scholar google search
Bonnet R., Pavlovic S., Lehmann J., Rommelspacher H. (2004) The strong inhibition of triosephosphate isomerase by the natural beta-carbolines may explain their neurotoxic actions. Neuroscience, 127(2), 443–453. CrossRef Scholar google search
Machnicka B., Grochowalska R., Bogusławska D.M., Sikorski A.F., Lecomte M.C. (2012) Spectrin-based skeleton as an actor in cell signaling. Cell. Mol. Life Sci., 69(2), 191–201. CrossRef Scholar google search
de Matteis M.A., Morrow J.S. (2000) Spectrin tethers and mesh in the biosynthetic pathway. J. Cell Sci., 113(Pt 13), 2331–2343. CrossRef Scholar google search
Sangerman J., Kakhniashvili D., Brown A., Shartava A., Goodman S.R. (2001) Spectrin ubiquitination and oxidative stress: potential roles in blood and neurological disorders. Cell. Mol. Biol. Lett., 6(3), 607–636. Scholar google search
Sharapov M.G., Gudkov S.V. (2021) Peroxiredoxin 1 — multifunctional antioxidant enzyme, protects from oxidative damages and increases the survival rate of mice exposed to total body irradiation. Arch. Biochem. Biophys., 697, 108671. CrossRef Scholar google search
Roede J.R., Hansen J.M., Go Y.-M., Jones D.P. (2011) Maneb and paraquat-mediated neurotoxicity: involvement of peroxiredoxin/thioredoxin system. Toxicol. Sci., 121(2), 368–375. CrossRef Scholar google search
Addison W.N., Pellicelli M., St-Arnaud R. (2019) Dephosphorylation of the transcriptional cofactor NACA by the PP1A phosphatase enhances cJUN transcriptional activity and osteoblast differentiation. J. Biol. Chem., 294(20), 8184–8196. CrossRef Scholar google search
Labbadia J., Morimoto R.I. (2015) The biology of proteostasis in aging and disease.Annu. Rev. Biochem., 84, 435–464. CrossRef Scholar google search
Kelly C.J., Couch R.K., Ha V.T., Bodart C.M., Wu J., Huff S., Herrel N.T., Kim H.D., Zimmermann A.O., Shattuck J., Pan Y.-C., Kaeberlein M., Grillo A.S. (2023) Iron status influences mitochondrial disease progression in Complex I-deficient mice. eLife, 12, e75825. CrossRef Scholar google search
Shamilov R., Robinson V.L., Aneskievich B.J. (2021) Seeing keratinocyte proteins through the looking glass of intrinsic disorder. Int. J. Mol. Sci., 22(15), 7912. CrossRef Scholar google search
Henrich M.T., Oertel W.H., Surmeier D.J., Geibl F.F. (2023) Mitochondrial dysfunction in Parkinson’s disease — a key disease hallmark with therapeutic potential. Mol. Neurodegener., 18, 83. CrossRef Scholar google search
Terenzio M., di Pizio A., Rishal I., Marvaldi L., di Matteo P., Kawaguchi R., Coppola G., Schiavo G., Fisher E.M.C., Fainzilber M. (2020) DYNLRB1 is essential for dynein mediated transport and neuronal survival. Neurobiol. Dis., 140, 104816. CrossRef Scholar google search
Ripon M.K.H., Lee H., Dash R., Choi H.J., Oktaviani D.F., Moon I.S., Haque M.N. (2020) N-acetyl-D-glucosamine kinase binds dynein light chain roadblock 1 and promotes protein aggregate clearance. Cell Death Dis., 11(8), 619. CrossRef Scholar google search
Barbosa D.J., Carvalho C., Costa I., Silva R. (2025) Molecular motors in myelination and their misregulation in disease. Mol. Neurobiol., 62(4), 4705–4723. CrossRef Scholar google search
Kawahata I., Sekimori T., Oizumi H., Takeda A., Fukunaga K. (2023) Using fatty acid-binding proteins as potential biomarkers to discriminate between Parkinson’s disease and dementia with Lewy bodies: exploration of a novel technique. Int. J. Mol. Sci., 24(17), 13267. CrossRef Scholar google search
Kawahata I., Fukunaga K. (2023) Pathogenic impact of fatty acid-binding proteins in Parkinson’s diseasepotential biomarkers and therapeutic targets. Int. J. Mol. Sci., 24(23), 17037. CrossRef Scholar google search
Lai P.M., Chan K.M. (2024) Roles of histone H2A variants in cancer development, prognosis, and treatment. Int. J. Mol. Sci., 25(6), 3144. CrossRef Scholar google search
Gebremedhin K.G., Rademacher D.J. (2016) Histone H3 acetylation in the postmortem Parkinson’s disease primary motor cortex. Neurosci. Lett., 627, 121–125. CrossRef Scholar google search
Mao Q., Luo Z., Wang K., Chen B., Wang Z., Zhang Y., Wang X., Luo X. (2024) Modifications on histone tails in Parkinson’s disease. SciBase Neurol., 2(2), 1017. Scholar google search
Zhang L.-Y., Zhang S.-Y., Wen R., Zhang T.-N., Yang N. (2024) Role of histone deacetylases and their inhibitors in neurological diseases. Pharmacol. Res., 208, 107410. CrossRef Scholar google search
Saintilnord W.N., Hegazy Y.A., Chesnutt K., Eckstein M., Cassidy R.N., Dhahri H., Bennett R.L., Melters D.P., Lopes E., Fu Z., Lau K., Chandler D.P., Poirier M.G., Dalal Y., Licht J.D., Fondufe-Mittendorf Y. (2024) Aberrant expression of histone H2B variants reshape chromatin and alter oncogenic gene expression programs. bioRxiv [Preprint], 2024.11.18.624207. CrossRef Scholar google search
Huang C.-M., Chen L.-Y. (2024) Histone variant H3.3 mediates DNA repair and cGAS-STING pathway activation in telomere dysfunction. bioRxiv [Preprint], 2024.08.07.606966. CrossRef Scholar google search
Park G., Tan J., Garcia G., Kang Y., Salvesen G., Zhang Z. (2016) Regulation of histone acetylation by autophagy in Parkinson disease. J. Biol. Chem., 291(7), 3531–3540. CrossRef Scholar google search
Lazarev V.F., Guzhova I.V., Margulis B.A. (2020) Glyceraldehyde-3-phosphate dehydrogenase is a multifaceted therapeutic target. Pharmaceutics, 12(5), 416. CrossRef Scholar google search
Buneeva O.A., Kapitsa I.G., Kazieva L.S., Vavilov N.E., Zgoda V.G., Medvedev A.E. (2024) The delayed effect of rotenone on the relative content of brain isatin-binding proteins of rats with experimental parkinsonism. Biomeditsinskaya Khimiya, 70(1), 25–32. CrossRef Scholar google search
Medvedev A., Buneeva O., Gnedenko O., Fedchenko V., Medvedeva M., Ivanov Y., Glover V., Sandler M. (2006) Isatin interaction with glyceraldehyde-3-phosphate dehydrogenase, a putative target of neuroprotective drugs: partial agonism with deprenyl. In: Oxidative Stress and Neuroprotection (Parvez H., Riederer P., eds.). Journal of Neural Transmission. Supplementa, vol. 71. Springer, Vienna, pp. 97–103. CrossRef Scholar google search
Amran N. (2026) Tubulin α-1C chain as a central signalling hub in carcinogenesis: towards a conceptual framework. Biochem. Biophys. Res. Commun., 800, 153285. CrossRef Scholar google search
Ren Y., Zhao J., Feng J. (2003) Parkin binds to α/β tubulin and increases their ubiquitination and degradation. J. Neurosci., 23(8), 3316–3324. CrossRef Scholar google search
Mazzetti S., Giampietro F., Calogero A.M., Isilgan H.B., Gagliardi G., Rolando C., Cantele F., Ascagni M., Bramerio M., Giaccone G., Isaias I.U., Pezzoli G., Cappelletti G. (2024) Linking acetylated α-tubulin redistribution to α-synuclein pathology in brain of Parkinson’s disease patients. NPJ Parkinsons Dis., 10, 2. CrossRef Scholar google search
Hammond J.W., Cai D., Verhey K.J. (2008) Tubulin modifications and their cellular functions. Curr. Opin. Cell Biol., 20(1), 71–76. CrossRef Scholar google search
Binarová P., Tuszynski J. (2019) Tubulin: structure, functions and roles in disease. Cells, 8(10), 1294. CrossRef Scholar google search
Michurina S., Beloglazova I., Agareva M., Alekseeva N., Parfyonova Y., Stafeev I. (2025) Creation of genetically modified adipocytes for tissue engineering: creatine kinase B overexpression leads to stimulated glucose uptake and mitochondrial potential growth, but lowered lipid synthesis. Life (Basel), 15(5), 753. CrossRef Scholar google search
Vassilopoulos D., Jockers-Wretou E. (1987) Serum creatine kinase B levels in diseases of the central nervous system. Eur. Neurol., 27(2), 78–81. CrossRef Scholar google search
van Laar V.S., Dukes A.A., Cascio M., Hastings T.G. (2008) Proteomic analysis of rat brain mitochondria following exposure to dopamine quinone: implications for Parkinson disease. Neurobiol. Dis., 29(3), 477–489. CrossRef Scholar google search
Zhao Y., Xing C., Peng H. (2024) ALYREF (Aly/REF export factor): a potential biomarker for predicting cancer occurrence and therapeutic efficacy. Life Sci., 338, 122372. CrossRef Scholar google search
Piergiorge R.M., de Vasconcelos A.T.R.D., Santos-Rebouças C.B. (2024) Understanding the (epi)genetic dysregulation in Parkinson’s disease through an integrative brain competitive endogenous RNA network. Mech. Ageing Dev., 219, 111942. CrossRef Scholar google search
Liu L., Zhao Y.-J., Zhang F. (2025) RNA methylation modifications in neurodegenerative diseases: focus on their enzyme system. J. Adv. Res., 77, 535–549. CrossRef Scholar google search
Alieva I.B., Shakhov A.S., Dayal A.A., Churkina A.S., Parfenteva O.I., Minin A.A. (2024) Unique role of vimentin in the intermediate filament proteins family. Biochemistry (Moscow), 89(4), 726–736. CrossRef Scholar google search
Schneider Y., Koller A., Schweigert A., Andert M., Hoffmann L., O’Brien S., Seebauer L., Plötz S., Kielkowski P., Winkler J., Schlachetzki J.C.M., Xiang W. (2025) Vimentin network dysregulation mediates neurite deficits in SNCA duplication Parkinson’s patient-derived midbrain neurons. Sci. Adv., 11(23), eadq2742. CrossRef Scholar google search
Pirovich D.B., Da’dara A.A., Skelly P.J. (2021) Multifunctional fructose 1,6-bisphosphate aldolase as a therapeutic target. Front. Mol. Biosci., 8, 719678. CrossRef Scholar google search
Chen B., Zhang Q., Zhong X., Zhang X., Liu X., Wang H., Yang F., Zhang J., Huang J., Wong Y.-K., Luo P., Wang J., Sun J. (2024) Dopamine modification of glycolytic enzymes impairs glycolysis: possible implications for Parkinson’s disease. Cell Commun. Signal., 22, 75. CrossRef Scholar google search
Dukes A.A., van Laar V.S., Cascio M., Hastings T.G. (2008) Changes in endoplasmic reticulum stress proteins and aldolase A in cells exposed to dopamine. J. Neurochem., 106(1), 333–346. CrossRef Scholar google search
Helfman D.M., Kuo J.F. (1982) A homogeneous cyclic CMP phosphodiesterase hydrolyzes both pyrimidine and purine cyclic 2':3'- and 3':5'-nucleotides. J. Biol. Chem., 257(2), 1044–1047. Scholar google search
Takagi S., Hayakawa N., Kimoto H., Kato H., Araki T. (2007) Damage to oligodendrocytes in the striatum after MPTP neurotoxicity in mice. J. Neural Transm., 114(12), 1553–1557. CrossRef Scholar google search
Balasubramanian P., Vijayarangam V., Deviparasakthi M.K.G., Palaniyandi T., Ravi M., Natarajan S., Viswanathan S., Baskar G., Wahab M.R.A., Surendran H. (2024) Implications and progression of peroxiredoxin 2 (PRDX2) in various human diseases. Pathol. Res. Pract., 254, 155080. CrossRef Scholar google search
Liu J., Su G., Gao J., Tian Y., Liu X., Zhang Z. (2020) Effects of peroxiredoxin 2 in neurological disorders: a review of its molecular mechanisms. Neurochem. Res., 45(4), 720–730. CrossRef Scholar google search
Schittek B. (2012) The multiple facets of dermcidin in cell survival and host defense. J. Innate Immun., 4(4), 349–360. CrossRef Scholar google search
Yong S.J., Teoh S.L., Parhar I.S., Soga T., Lim W.L., Chew J. (2025) Antimicrobial peptides and proteins in Alzheimer’s and Parkinson’s diseases: implications for biomarker exploration. Rev. Neurosci., 36(8), 849–879. CrossRef Scholar google search
Hynes R.O., Yamada K.M. (1982) Fibronectins: multifunctional modular glycoproteins. J. Cell Biol., 95(2 Pt 1), 369–377. CrossRef Scholar google search
Zhu S., Li H., Huang Z., Zeng Y., Huang J., Li G., Yang S., Zhou H., Chang Z., Xie Z., Que R., Wei X., Li M., Liang Y., Xian W., Li M., Pan Y., Huang F., Shi L., Yang C., Deng C., Batzu L., Poplawska-Domaszewicz K., Chen S., Chan L.-L., Ray Chaudhuri K., Tan E.-K., Wang Q. (2025) Plasma fibronectin is a prognostic biomarker of disability in Parkinson’s disease: a prospective, multicenter cohort study. NPJ Parkinsons Dis., 11, 1. CrossRef Scholar google search
Oikonomou K.G., Zachou K., Dalekos G.N. (2011) Alpha-actinin: a multidisciplinary protein with important role in B-cell driven autoimmunity. Autoimmun. Rev., 10(7), 389–396. CrossRef Scholar google search
Sahni A., Sahni S.K. (2026) Fibrinogen and fibrin as growth factor regulators: pathological implications, translational opportunities. Biomolecules, 16(2), 335. CrossRef Scholar google search
Huang Z., Zheng J., Yuan F., Zhong H., Yu R., Luo Y., Zhang M., Chen S., Shen B., Xie Z., Yang W., Zhu S., Que R., Xie F., Liu H., Yang W., Zhang L., Zheng W., Jin K., Deng C., Xiao B., Foo J.N., Chan L.-L., Lin C.-H., Zhou Z.D., Tan E.-K., Wang Q. (2026) Fibrinogen exacerbates α-synuclein aggregation and mitochondrial dysfunction via alpha5beta3 integrin in Parkinson’s disease. J.Adv. Res., 81, 551–568. CrossRef Scholar google search
Wang X., Jiang S., Di L., Li S., Chen H., Huang P., Cao T., Jin W., Huang L. (2026) Fibrinogen drives neuroinflammation and neuropathology in perioperative neurocognitive disorders. Int. Immunopharmacol., 168(Pt 2), 115906. CrossRef Scholar google search
Zininga T., Ramatsui L., Shonhai A. (2018) Heat shock proteins as immunomodulants. Molecules, 23(11), 2846. CrossRef Scholar google search
Rocha S., Freitas A., Guimaraes S., Vitorino R., Aroso M., Gomez-Lazaro M. (2018) Biological implications of differential expression of mitochondrial-shaping proteins in Parkinson’s disease. Antioxidants (Basel), 7(1), 1. CrossRef Scholar google search
Turturici G., Sconzo G., Geraci F. (2011) Hsp70 and its molecular role in nervous system diseases. Biochem. Res. Int., 2011, 618127. CrossRef Scholar google search
Li X., WangW., Pan S., Cao X., Thomas E.R., XieM., Zhang C., Wu J. (2024) Exploring heat shock proteins as therapeutic targets for Parkinson’s disease. Biochem. Pharmacol., 230(Pt 3), 116633. CrossRef Scholar google search
Shi H., Fang W., Liu M., Fu D. (2017) Complement component 1, q subcomponent binding protein (C1QBP) in lipid rafts mediates hepatic metastasis of pancreatic cancer by regulating IGF-1/IGF-1R signaling. Int. J. Cancer, 141(7), 1389–1401. CrossRef Scholar google search
Barna J., Dimén D., Puska G., Kovács D., Csikós V., Oláh S., Udvari E.B., Pál G., Dobolyi Á. (2019) Complement component 1q subcomponent binding protein in the brain of the rat. Sci. Rep., 9, 4597. CrossRef Scholar google search
Bohush A., Leśniak W., Weis S., Filipek A. (2021) Calmodulin and its binding proteins in Parkinson’s disease. Int. J. Mol. Sci., 22(6), 3016. CrossRef Scholar google search
Hurley M.J., Brandon B., Gentleman S.M., DexterD.T. (2013) Parkinson’s disease is associated with altered expression of CaV1 channels and calcium-binding proteins. Brain, 136(Pt 7), 2077–2097. CrossRef Scholar google search
O’Day D.H. (2024) The complex interplay between toxic hallmark proteins, calmodulin-binding proteins, ion channels, receptors involved in calcium dyshomeostasis in neurodegeneration. Biomolecules, 14(2), 173. CrossRef Scholar google search
Buneeva O.A., Medvedev A.E. (2017) Atypical ubiquitination of proteins. Biomeditsinskaya Khimiya, 62(5), 496–509. CrossRef Scholar google search
Buneeva O., Medvedev A. (2022) Atypical ubiquitination and Parkinson’s disease. Int. J. Mol. Sci., 23(7), 3705. CrossRef Scholar google search
McKeon J.E., Sha D., Li L., Chin L.-S. (2015) Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagylysosome system. Cell. Mol. Life Sci., 72(9), 1811–1824. CrossRef Scholar google search
Boggs J.M. (2006) Myelin basic protein: a multifunctional protein. Cell. Mol. Life Sci., 63(17), 1945–1961. CrossRef Scholar google search
Maass F., Canaslan S., van Riesen C., Hermann P., Schmitz M., Schulte C., Brockmann K., Synofzik M., Bähr M., Zerr I. (2025) Myelin basic protein and TREM2 quantification in the CSF of patients with Multiple System Atrophy and other Parkinsonian conditions. J. Neurol., 272(1), 52. CrossRef Scholar google search
Sanchez-Niño M.D., Sanz A.B., Lorz C., Gnirke A., Rastaldi M.P., Nair V., Egido J., Ruiz-Ortega M., Kretzler M., Ortiz A. (2010) BASP1 promotes apoptosis in diabetic nephropathy. J. Am. Soc. Nephrol., 21(4), 610–621. CrossRef Scholar google search
Chung D., Shum A., Caraveo G. (2020) GAP-43 and BASP1 in axon regeneration: implications for the treatment of neurodegenerative diseases. Front. Cell Dev. Biol., 8, 567537. CrossRef Scholar google search
Buneeva O.A., Fedchenko V.I., Kaloshina S.A., Zavyalova M.G., Zgoda V.G., Medvedev A.E. (2025) Interaction of kidney proteins of normal and hypertensive rats with fragments of renalase peptide RP220. Biomeditsinskaya Khimiya, 71(2), 103–115. CrossRef Scholar google search
